Wiley.com
Print this page Share

Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad

Chuang Lu (Editor), Albert P. Li (Editor)
ISBN: 978-0-470-28174-1
Hardcover
876 pages
January 2010
List Price: US $233.00
Government Price: US $161.24
Enter Quantity:   Buy
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad (047028174X) cover image

Chuang Lu, PhD, is the Associate Director in the Drug Safety and Disposition Department of Millennium Pharmaceuticals. His current research interests include drug-metabolizing enzymes, drug–drug interaction, and in vitro–in vivo correlation.

Albert P. Li, PhD, is the President and CEO of In Vitro ADMET Laboratories, LLC and Advanced Pharmaceutical Sciences, Inc., and the cofounder, Chairman, and CSO of the ADMET Group. His experience spans over twenty-five years in the drug development industry, with over 150 publications. He is the editor of several books, including Drug–Drug Interactions in Pharmaceutical Development, published by Wiley.

More By These Authors

Albert P. Li (Editor), Binghe Wang
Back to Top